Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2011-5-31
pubmed:abstractText
The choice of promoter is a critical step in optimizing the efficiency and stability of recombinant protein production in mammalian cell lines. Artificial promoters that provide stable expression across cell lines and can be designed to the desired strength constitute an alternative to the use of viral promoters. Here, we show how the nucleotide characteristics of highly active human promoters can be modelled via the genome-wide frequency distribution of short motifs: by overlapping motifs that occur infrequently in the genome, we constructed contiguous sequence that is rich in GC and CpGs, both features of known promoters, but lacking homology to real promoters. We show that snippets from this sequence, at 100 base pairs or longer, drive gene expression in vitro in a number of mammalian cells, and are thus candidates for use in protein production. We further show that expression is driven by the general transcription factors TFIIB and TFIID, both being ubiquitously present across cell types, which results in less tissue- and species-specific regulation compared to the viral promoter SV40. We lastly found that the strength of a promoter can be tuned up and down by modulating the counts of GC and CpGs in localized regions. These results constitute a "proof-of-concept" for custom-designing promoters that are suitable for biotechnological and medical applications.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/21625601-10022924, http://linkedlifedata.com/resource/pubmed/commentcorrection/21625601-11237011, http://linkedlifedata.com/resource/pubmed/commentcorrection/21625601-11765852, http://linkedlifedata.com/resource/pubmed/commentcorrection/21625601-12381658, http://linkedlifedata.com/resource/pubmed/commentcorrection/21625601-12620064, http://linkedlifedata.com/resource/pubmed/commentcorrection/21625601-12651739, http://linkedlifedata.com/resource/pubmed/commentcorrection/21625601-12782648, http://linkedlifedata.com/resource/pubmed/commentcorrection/21625601-15075390, http://linkedlifedata.com/resource/pubmed/commentcorrection/21625601-15193307, http://linkedlifedata.com/resource/pubmed/commentcorrection/21625601-15706513, http://linkedlifedata.com/resource/pubmed/commentcorrection/21625601-15988478, http://linkedlifedata.com/resource/pubmed/commentcorrection/21625601-15995697, http://linkedlifedata.com/resource/pubmed/commentcorrection/21625601-16500937, http://linkedlifedata.com/resource/pubmed/commentcorrection/21625601-16645617, http://linkedlifedata.com/resource/pubmed/commentcorrection/21625601-17593382, http://linkedlifedata.com/resource/pubmed/commentcorrection/21625601-18252004, http://linkedlifedata.com/resource/pubmed/commentcorrection/21625601-18436437, http://linkedlifedata.com/resource/pubmed/commentcorrection/21625601-18585359, http://linkedlifedata.com/resource/pubmed/commentcorrection/21625601-19443739, http://linkedlifedata.com/resource/pubmed/commentcorrection/21625601-19493895, http://linkedlifedata.com/resource/pubmed/commentcorrection/21625601-19494347, http://linkedlifedata.com/resource/pubmed/commentcorrection/21625601-19762556, http://linkedlifedata.com/resource/pubmed/commentcorrection/21625601-20210750, http://linkedlifedata.com/resource/pubmed/commentcorrection/21625601-20478019, http://linkedlifedata.com/resource/pubmed/commentcorrection/21625601-2423876, http://linkedlifedata.com/resource/pubmed/commentcorrection/21625601-2777259, http://linkedlifedata.com/resource/pubmed/commentcorrection/21625601-3656447, http://linkedlifedata.com/resource/pubmed/commentcorrection/21625601-8450755
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1932-6203
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
e20136
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Exploiting nucleotide composition to engineer promoters.
pubmed:affiliation
Broad Institute, Cambridge, Massachusetts, United States of America.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural